http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2998291-C
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45ce1bffe51cf2b329d5d00f9a99689f |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 |
filingDate | 2015-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fcd23aa08178a705d5dce4dbc676400 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3675952fbe2f57ec84fe66ac326af08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f5417641595719ca281a6c63f5f3a12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bb0ed459c0afe90ad9c07896750eb99 |
publicationDate | 2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2998291-C |
titleOfInvention | Acetogenin molecules having antiplatelet and/or antithrombic activities, and methods and compositions thereof |
abstract | The present disclosure relates, according to some embodiments, to acetogenin molecules that may have antiplatelet and/or antithronibic activities. In some embodiments, the present disclosure relates to an acetogenin molecule selected from the group comprising: Acetogenin 1, Acetogenin 2, Acetogenin 3, Acetogenin 4, Acetogenin 5, Acetogenin 6, Acetogenin 7, Acetogenin 8, Acetogenin 9, Acetogenin 10, Acetogenin 1 1, Acetogenin 12, Acetogenin 13, and Acetogenin 14. The present disclosure relates in some embodiments to a pharmaceutical composition comprising a first acetogenin molecule and a delivery vehicle, wherein the first acetogenin molecule is selected from the group comprising: Acetogenin 1, Acetogenin 2, Acetogenin 3, Acetogenin 4, Acetogenin 5, Acetogenin 6, Acetogenin 7, Acetogenin 8, Acetogenin 9, Acetogenin 10, Acetogenin 1 1, Acetogenin 12, Acetogenin 13, and Acetogenin 14. |
priorityDate | 2015-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.